Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT06763172
Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI (Caffeine-RAC)
Measure Striatal Adenosine-dopamine Receptors Interactions: from Molecule to Behaviors
Sponsor: Hsiao-Ying Wey
Interventions
Caffeine (200 mg) Placebo
Updated 1 time since 2025 Last updated: Jan 7, 2025 Started: May 17, 2023 Primary completion: Dec 31, 2026 Completion: Dec 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06763172, this PHASE4 trial focuses on Adenosine and Caffeine and remains actively recruiting participants. Sponsored by Hsiao-Ying Wey, it has been updated 1 time since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Hsiao-Ying Wey
Data source: Martinos Center for Biomedical Imaging
For direct contact, visit the study record on ClinicalTrials.gov .